Mycobacterial antigens expressed during latency
View Patent ↗A method is provided for identifying mycobacterial genes that are induced or up-regulated under culture conditions that are nutrient-starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of a micobacterium for at least 20 days post-inoculation, when compared with culture conditions that are not nutrient-starving and which support exponential growth of said mycobacterium . Said induced or up-regulated genes form the basis of nucleic acid vaccines, or provide targets to allow preparation of attenuated mycobacteria for vaccines against mycobacterial infections. Similarly, peptides encoded by said induced or up-regulated genes are employed in vaccines. In a further embodiment, the identified genes/peptides provide the means for identifying the presence of a mycobacterial infection in a clinical sample by nucleic acid probe or antibody detection.
1. An isolated M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129 or a variant thereof having at least 70% amino acid homology therewith, or a fusion protein thereof, wherein said fusion protein or variant has a common antigenic cross-reactivity to said isolated peptide; wherein the peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
2. A therapeutic agent for combating mycobacterial infections, comprising an M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, or a fusion protein thereof, wherein said fusion protein has a common antigenic cross-reactivity to said peptide; wherein the peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
3. A method of treating an M. tuberculosis infection, by administering to a patient an M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, or a fusion protein thereof, wherein said fusion protein has a common antigenic cross-reactivity to said peptide; wherein the peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
4. A method of diagnosing a mycobacterial infection, comprising the steps:
(i) incubating a biological sample with an isolated M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129 wherein the peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium ; and
(ii) detecting antibodies to mycobacteria , wherein said antibodies bind to said isolated peptide, and thereby detecting mycobacterial infection.
5. A diagnostic reagent for identifying a mycobacterial infection, comprising an isolated M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, or a fusion protein thereof, wherein said fusion protein has a common antigenic cross-reactivity to said peptide; wherein the peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
6. An isolated peptide, wherein said peptide is:
(i) a fragment of an M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, wherein said fragment has at least 35 amino acids;
(ii) a variant of (i) having at least 70% amino acid homology therewith; or
(iii) a fusion protein of (i) or (ii);
wherein said fragment, variant or fusion protein has a common antigenic cross-reactivity to said M. tuberculosis peptide; wherein the M. tuberculosis peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
7. A therapeutic agent for combating mycobacterial infections, comprising an isolated peptide, wherein said isolated peptide is:
(i) a variant having at least 90% amino acid homology to a peptide selected from the group consisting of:
(a) an M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129; and
(b) a fragment of (a) having at least 35 amino acid residues; or
(ii) a fusion protein of (i);
wherein said fragment, variant or fusion protein has a common antigenic cross-reactivity to said M. tuberculosis peptide; and
wherein the M. tuberculosis peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
8. A diagnostic reagent for identifying a mycobacterial infection, comprising an isolated peptide, wherein said isolated peptide is:
(i) a variant having at least 90% amino acid homology to a peptide selected from the group consisting of:
(a) an M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129; and
(b) a fragment of (a) having at least 35 amino acid residues; or
(ii) a fusion protein of (i);
wherein said variant, fragment or fusion protein has a common antigenic cross-reactivity to said M. tuberculosis peptide; and
wherein the M. tuberculosis peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
9. A therapeutic agent for combating mycobacterial infections, comprising an isolated peptide, wherein said peptide is:
(i) a fragment of an M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, wherein said fragment has at least 35 amino acid residues; or
(ii) a fusion protein of (i);
wherein said fragment, or fusion protein has a common antigenic cross-reactivity to said M. tuberculosis peptide; wherein the M. tuberculosis peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
10. A method of treating an M. tuberculosis infection, by administering to a patient an isolated peptide, wherein said peptide is:
(i) a fragment of an M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, wherein said fragment has at least 35 amino acids; or
(ii) a fusion protein of (i);
wherein said fragment or fusion protein has a common antigenic cross-reactivity to said M. tuberculosis peptide; wherein the M. tuberculosis peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
11. A method of diagnosing a mycobacterial infection, comprising the steps of:
(i) incubating a biological sample with an isolated peptide, wherein said isolated peptide is a fragment of an M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, wherein said fragment has at least 35 amino acids;
wherein said fragment, has a common antigenic cross-reactivity to said M. tuberculosis peptide; wherein the M. tuberculosis peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium; and
(ii) detecting antibodies to mycobacteria , wherein said antibodies bind to said fragment, and thereby detecting mycobacterial infection.
12. A diagnostic reagent for identifying a mycobacterial infection, comprising an isolated peptide, wherein said peptide is:
(i) a fragment of an M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, wherein said fragment has at least 35 amino acids; or
(ii) a fusion protein of (i);
wherein said fragment or fusion protein has a common antigenic cross-reactivity to said M. tuberculosis peptide; wherein the M. tuberculosis peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
13. A medicament for reducing the severity or intensity of a mycobacterial infection, or for preventing mycobacterial disease progression, by administering to a patient an M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 or 129, or a fusion protein thereof, wherein said fusion protein has a common antigenic cross-reactivity to said peptide; wherein the peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
14. A method of reducing the severity or intensity of a mycobacterial infection, or of preventing mycobacterial disease progression, by administering to a patient an isolated peptide, wherein said isolated peptide is:
(i) a fragment of an M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, wherein said fragment has at least 35 amino acids; or
(ii) a fusion protein of (i);
wherein said fragment or fusion protein has a common antigenic cross-reactivity to said M. tuberculosis peptide; and
wherein the M. tuberculosis peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
15. An isolated peptide, wherein said peptide is:
(i) a fragment of a polypeptide, wherein said polypeptide is a variant having at least 90% amino acid homology with an isolated M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, wherein said fragment has at least 35 amino acids residues; or
(ii) a fusion protein of (i);
wherein said fragment, variant or fusion protein has a common antigenic cross-reactivity to said M. tuberculosis peptide; and wherein the M. tuberculosis peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
16. A therapeutic agent for combating mycobacterial infections, comprising an isolated peptide, wherein said isolated peptide is:
(i) a fragment of a polypeptide, wherein said polypeptide is a variant having at least 90% amino acid homology with an isolated M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, wherein said fragment has at least 35 amino acids; or
(ii) a fusion protein of (i);
wherein said fragment, variant or fusion protein has a common antigenic cross-reactivity to said isolated M. tuberculosis peptide; and
wherein the M. tuberculosis peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .
17. A diagnostic reagent for identifying a mycobacterial infection, comprising an isolated peptide, wherein said peptide is:
(i) a fragment of a polypeptide, wherein said polypeptide is a variant having at least 90% amino acid homology with an isolated M. tuberculosis peptide selected from the group consisting of SEQ ID NOs: 7, 55, 125 and 129, wherein said fragment has at least 35 amino acids; or
(ii) a fusion protein of (i);
wherein said fragment, variant or fusion protein has a common antigenic cross-reactivity to said isolated M. tuberculosis peptide; and
wherein the M. tuberculosis peptide is encoded by an M. tuberculosis gene the expression of which is induced or up regulated under culture conditions that are nutrient starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of an M. tuberculosis micobacterium for at least 40 days post inoculation, when compared with culture conditions that are not nutrient starving and which support exponential growth of said mycobacterium .